Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Controversy Persists Over House Pre-emption Provision

This article was originally published in The Gray Sheet

Executive Summary

Device industry support for the House medical device user fee reauthorization bill is threatened by language that companies say would make them more vulnerable to patient lawsuits

You may also be interested in...



Democrats Seek To Overturn Supreme Court Device Liability Decision

Democratic leaders in Congress are vowing to craft legislation to effectively overturn the Supreme Court's ruling that PMA approval pre-empts a patient's right to sue device companies for personal injury

Democrats Seek To Overturn Supreme Court Device Liability Decision

Democratic leaders in Congress are vowing to craft legislation to effectively overturn the Supreme Court's ruling that PMA approval pre-empts a patient's right to sue device companies for personal injury

Capitol Hill Roundup: Many Med-Tech Issues Are In Play For 2008

Health care may not have been the most debated issue on Capitol Hill in 2007, but it was close, and issues impacting the medical technology sector were in abundance

Related Content

UsernamePublicRestriction

Register

MT024910

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel